CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEunyoung Kang, Michael S. Anglesio, Beyhan Ataseven et al.|Cancer|2022Cited by 46
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|The Journal of Pathology|2021Cited by 42
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Eunyoung Kang et al.|The Journal of Pathology Clinical Research|2023Cited by 29
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S. Meagher, Kayla Klett, Kylie L. Gorringe et al.|Clinical Cancer Research|2022Cited by 22
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H. Nelson, Brenda Y. Hernandez, Naoko Sasamoto et al.|Journal of Clinical Investigation|2024Cited by 19